IDXX - CIK 0000874716
The table below shows IDEXX LABORATORIES INC /DE's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.18B | $929.00M | $906.51M | $542.98M | $755.55M | $648.06M |
| Capital expenditure | $124.68M | $120.92M | $133.63M | $148.84M | $119.55M | $106.96M |
| Investing cash flow | -$136.24M | -$207.06M | -$125.25M | -$195.35M | -$292.97M | -$109.38M |
| Dividends paid | - | - | - | - | - |
IDEXX LABORATORIES INC /DE reported operating cash flow of $1.18B for fiscal year 2025. That is up 27.2% from $929.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $235.85M (FY 2014) to $1.18B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $1.22B | $837.03M | $71.92M | $819.71M | $746.78M | $182.81M |
| Financing cash flow | -$1.16B | -$878.07M | -$442.00M | -$370.94M | -$697.41M | -$248.42M |